- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05229887
Confirmation of Tube Placement in Newborns
Tracheal intubation remains a common procedure in the neonatal intensive care unit (NICU) and the delivery room (DR).
Current guidelines recommend Estimation of correct endotracheal tube (ETT) insertion Our hospital policy recommends to estimate the correct depth (cm) of tube placement by measuring the nasal-ear-tragus length using the "7-8-9 rule" when the endotracheal tube is placed orally. Using this formula an infant weighing 1kg would be intubated to a depth of 7cm, a 2kg infant to a depth of 8cm, and a 3kg infant to a depth of 9cm from the upper lip.
With the new 2015 guidelines, ETT depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm or by using the "initial endotracheal tube insertion depth" table. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.
However, studies using NTL reported that using this technique only resulted in correct ETT placement in 56% of cases.
Every ETT has markings on the tube, which are called vocal cord markings, which are to be used to provide a guidance to how deep to place the ETT into the trachea. There has been npc study to compare the vocal cord markings with the current approach of NTL.
The current study aims to determine if the use of vocal cord markings during intubation increases percentage of correct endotracheal tube placement compared to NTL in preterm and term infants.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T5H 3V9
- Royal Alexandra Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All infants (term and preterm) born at The Royal Alexandra Hospital who require endotracheal intubation in the delivery room or/and Neonatal Intensive Care Unit will be eligible.
Exclusion Criteria:
- Infants will be excluded if their parents refuse to give consent to this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nostril-Tragus-Length
|
Endotracheal tube depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear. |
|
Experimental: Vocal cord markings
|
The endotracheal tube has markings on the tube, which are called vocal cord markings, which will be used to provide a guidance to how deep to place the ETT into the trachea.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of endotracheal tubes correctly placed within the trachea
Time Frame: within 30 minutes after endotracheal intubation
|
within 30 minutes after endotracheal intubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality in the Neonatal Intensive Care Unit
Time Frame: 0-200 days
|
We will record the number of infants who die during their admission
|
0-200 days
|
|
Necrotizing Enterocolitis
Time Frame: 0-200 days
|
We will record the number of infants who are diagnosed with Necrotizing Enterocolitis
|
0-200 days
|
|
Patent Ductus Arteriosus
Time Frame: 0-200 days
|
We will record the number of infants who are diagnosed with Patent Ductus Arteriosus
|
0-200 days
|
|
Intraventricular hemorrhage all grades
Time Frame: 0-200 days
|
We will record the number of infants who are diagnosed with intraventricular hemorrhage
|
0-200 days
|
|
Bronchopulmonary Dysplasia at
Time Frame: 36 weeks corrected gestational age
|
We will record the number of infants who are diagnosed with Bronchopulmonary Dysplasia
|
36 weeks corrected gestational age
|
|
Changes in oxygen saturation during intubation procedure
Time Frame: 0 to 60 seconds
|
During intubation we will record the lowest oxygen saturation
|
0 to 60 seconds
|
|
Changes in Heart rate during intubation procedure
Time Frame: 0 to 60 seconds
|
During intubation we will record the lowest heart rate.
|
0 to 60 seconds
|
|
Duration of Intubation procedure
Time Frame: 0 to 60 seconds
|
During Intubation, we will measure time from end of mask ventilation to connection of the ventilation device to ETT
|
0 to 60 seconds
|
|
Airway injury observed during intubation (including blood, swollen cords, vocal cord redness)
Time Frame: 0 to 60 seconds
|
Observed by the person who performs the intubation by looking for blood, swollen cords, redness.
There is no score or questionnaire.
The operator will only assess these with yes or no
|
0 to 60 seconds
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Georg Schmolzer, University of Alberta
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00116201
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.